Type of security: Stock
Sector: Health Care
Industry: Medical/Dental Instruments
The data is delayed by 15 minutes.
Description: NuVasive, Inc., a medical device company, develops and markets minimally disruptive surgical products and procedurally integrated solutions for the spine. Its products focus on applications for spine fusion surgery. The company?s principal product offering includes a minimally disruptive surgical platform, known Maximum Access Surgery (MAS) that includes its proprietary software-driven nerve detection and avoidance systems, NVM5 and NVJJB, and intra-operative monitoring (IOM) support; MaXcess, an integrated split-blade retractor system; and various specialized implants. Its spine surgery product line offerings comprise products for the thoracolumbar and the cervical spine, which are primarily used to enable access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. The company?s biologic product line offerings used to aid the spinal fusion process or bone healing consist of allograft (donated human tissue); Osteocel Plus, an allograft cellular matrix containing via
|Shares Outstanding||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||6.84%||Sales Growth - Q/Q||5.47%||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||3.69%||ROE||7.11%||ROI||4.18%|
|Current Ratio||5.17||Quick Ratio||3.93||Long Term Debt/Equity||0.67||Debt Ratio||0.2|
|Gross Margin||76.15%||Operating Margin||15.49%||Net Profit Margin||6.01%||Dividend Payout Ratio|
|Cash From Financing Activities||-26.25 M||Cash From Investing Activities||-72.14 M||Cash From Operating Activities||35.18 M||Gross Profit||154.5 M|
|Net Profit||10.27 M||Operating Profit||25.86 M||Total Assets||1.29 B||Total Current Assets||684.33 M|
|Total Current Liabilities||132.44 M||Total Debt||368.5 M||Total Liabilities||618.32 M||Total Revenue||202.91 M|
|High 52 week||71.41||Low 52 week||44.53||Last close||58.1||Last change||-0.45%|
|RSI||70.47||Average true range||2.46||Beta||1||Volume||185.56 K|
|Simple moving average 20 days||8.32%||Simple moving average 50 days||14.45%||Simple moving average 200 days||0.25%|
|Performance Week||-0.84%||Performance Month||18.98%||Performance Quart||-5.53%||Performance Half||-17.34%|
|Performance Year||23.67%||Performance Year-to-date||17.23%||Volatility daily||3.21%||Volatility weekly||7.18%|
|Volatility monthly||14.71%||Volatility yearly||50.95%||Relative Volume||231.69%||Average Volume||804.48 K|
|New High||New Low|
2019-03-22 09:30:01 | NuVasive NUVA Down 1% Since Last Earnings Report: Can It Rebound?
2019-03-12 15:30:51 | Options Bears Jump on Battered NuVasive Stock
2019-03-12 10:31:46 | See what the IHS Markit Score report has to say about NuVasive Inc.
2019-03-06 13:39:00 | Why NuVasive Stock Rose 18% in February
2019-03-06 07:55:00 | Research Report Identifies E*TRADE Financial, Kennedy-Wilson, Alteryx, PTC Therapeutics, Ocean Power Technologies, and NuVasive with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
2019-03-05 16:05:00 | NuVasive To Participate In Cowen And Company 39th Annual Health Care Conference
2019-02-22 07:50:12 | NuVasive NUVA Q4 Earnings Beat Estimates, Margins Fall
2019-02-21 16:05:00 | NuVasive To Present At 8th Annual Leerink Partners Global Healthcare Conference
2019-02-21 14:17:47 | NuVasive NUVA Q4 2018 Earnings Conference Call Transcript
2019-02-21 05:58:03 | Edited Transcript of NUVA earnings conference call or presentation 20-Feb-19 9:30pm GMT
2019-02-20 18:21:00 | NuVasive Overcomes Industry Headwinds to Finish 2018 Strong
2019-02-20 17:40:10 | NuVasive NUVA Q4 Earnings and Revenues Top Estimates
2019-02-20 16:34:26 | NuVasive: 4Q Earnings Snapshot
2019-02-20 16:02:00 | NuVasive Reports Fourth Quarter And Full Year 2018 Financial Results
2019-02-20 14:30:00 | NuVasive, Inc. to Host Earnings Call
2019-02-13 10:31:03 | NuVasive NUVA Earnings Expected to Grow: Should You Buy?
2019-02-13 07:50:00 | New Research: Key Drivers of Growth for Plains Group Holdings, Cooper Tire & Rubber, NuVasive, Envestnet, Pacific Ethanol, and Mistras Group — Factors of Influence, Major Initiatives and Sustained Production
2019-02-12 10:21:33 | Jefferies Downgrades NuVasive, Says M&A Unlikely To Materialize
2019-02-12 00:00:24 | [$$] Morgan Stanley tests M&A waters with millennial millionaires play
2019-02-11 16:34:00 | Why NuVasive, Avis Budget Group, and Insperity Jumped Today
2019-02-11 16:20:00 | NuVasive Stock Surges on Report of Smith & Nephew Interest
2019-02-11 16:17:39 | Medical Stock Pops On Potential $3 Billion Smith & Nephew Takeover
2019-02-11 13:33:39 | Here’s why NuVasive, Inc.’s NASDAQ:NUVA Returns On Capital Matters So Much
2019-02-11 11:44:21 | NuVasive Stock Shoots Higher on Takeover Talk
2019-02-11 10:45:00 | Here's Why NuVasive Stock Is Soaring Today
2019-02-11 09:58:09 | Smith & Nephew Drops on Report of Deal Talks With NuVasive
2019-02-11 09:00:00 | Alphatec Announces Stay of Court Proceedings in NuVasive Patent Lawsuit
2019-02-11 06:37:00 | Trade Talks, Shutdown, NuVasive, Activision, Amazon - 5 Things You Must Know
2019-02-08 20:57:58 | Smith & Nephew in talks to buy NuVasive for over $3 billion - FT
2019-02-08 20:52:22 | Smith & Nephew in talks to buy NuVasive for over $3 bln - FT
2019-02-08 08:06:19 | See what the IHS Markit Score report has to say about NuVasive Inc.
2019-02-08 04:10:22 | [$$] Smith & Nephew in talks to buy NuVasive for over $3bn
2019-01-29 08:05:49 | See what the IHS Markit Score report has to say about NuVasive Inc.
2019-01-15 08:06:15 | See what the IHS Markit Score report has to say about NuVasive Inc.
2019-01-11 12:24:19 | Tamarack Capital Management’s Return, AUM, and Holdings
2019-01-10 08:12:12 | Did NuVasive, Inc. NASDAQ:NUVA Insiders Buy Up More Shares?
2019-01-10 08:03:02 | Why Globus Medical Stock Rose 10% on January 9
2019-01-09 08:06:55 | See what the IHS Markit Score report has to say about NuVasive Inc.
2019-01-07 17:20:00 | Stocks making the biggest moves after hours: Union Pacific, Lennar and more
2019-01-03 09:07:02 | Solid Global Business Aids NuVasive Amid Pricing Pressure
2018-12-27 16:05:00 | NuVasive To Participate In 37th Annual J.P. Morgan Healthcare Conference
2018-12-21 08:06:15 | See what the IHS Markit Score report has to say about NuVasive Inc.
2018-12-20 08:06:44 | See what the IHS Markit Score report has to say about NuVasive Inc.
2018-12-19 18:24:59 | See what the IHS Markit Score report has to say about NuVasive Inc.
2018-12-14 03:32:17 | NuVasive, Inc. NUVA: Are Hedge Funds Right About This Stock?